Skip to main content Accesibility Help
×
×
Home

High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands

  • L. MOLLEMA (a1), G. P. SMITS (a1), G. A. BERBERS (a1), F. R. VAN DER KLIS (a1), R. S. VAN BINNENDIJK (a1), H. E. DE MELKER (a1) and S. J. M. HAHNÉ (a1)...
Summary

Our aim was to assess progress towards measles elimination from The Netherlands by studying humoral measles immunity in the Dutch population. A population-based seroepidemiological study was conducted in 2006–2007 (N = 7900). Serum samples were analysed by a bead-based multiplex immunoassay. IgG levels ⩾0·2 IU/ml were considered protective. The overall seroprevalence in the Dutch population was 96%. However, 51% of socio-geographically clustered orthodox Protestant individuals aged <10 years were susceptible. Infants might be susceptible to measles between ages 4 months and 14 months, the age at which maternal antibodies have disappeared and the first measles, mumps, rubella (MMR) vaccination is administered, respectively. Waning of antibody concentrations was slower after the second MMR vaccination than after the first. The Netherlands is at an imminent risk of a measles outbreak in the orthodox Protestant minority. To prevent subsequent transmission to the general population, efforts to protect susceptible age groups are needed.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands
      Available formats
      ×
Copyright
Corresponding author
*Author for correspondence: Dr L. Mollema, National Institute for Public Health and the Environment, Epidemiology and Surveillance Unit, P.O. Box 1 (internal P.O. Box 75), 3720 BA Bilthoven, The Netherlands. (Email: Liesbeth.Mollema@rivm.nl)
References
Hide All
1. Simons, E, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012; 379: 21732178.
2. World Health Organization. Strategic plan for measles and congenital rubella infection in the WHO European Region. Copenhagen, Denmark: WHO Regional Office for Europe, 2003.
3. Khetsuriani, N, et al. Supplementary immunization activities to achieve measles elimination: experience of the European region. Journal Infectious Diseases 2011; 204 (Suppl. 1): 343352.
4. European Centre for Disease Prevention and Control (ECDC). European monthly measles monitoring (EMMO). Issue 10. Stockholm: ECDC, 2012.
5. Muscat, M. Who gets measles in Europe? Journal Infectious Diseases 2011; 204 (Suppl. 1): 353365.
6. Van Lier, EA, et al. Vaccination coverage national immunization program the Netherlands [in Dutch]. Bilthoven, The Netherlands: National Institute for Public Health and the Environment, 2012. Report 201001001/2012.
7. Ruijs, WL, et al. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health 2011; 11: 102.
8. Bijkerk, H, Bilkert-Mooiman, MA, Houtters, HJ. The immunization status of patients registered with measles during the 1987–88 epidemic [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 1989; 133: 2932.
9. Van der Zwan, CW, et al. Measles in the Netherlands: epidemiology and the effect of vaccination [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 1994; 138: 23902395.
10. Wallinga, J, van den Hof, S. Measles epidemiology in the Netherlands: an exploratory analysis of notification [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 2000; 144: 171174.
11. Van den Hof, S, Conyn-van Spaendonck, MAE, van Steenbergen, JE. Measles epidemic in the Netherlands, 1999–2000. Journal Infectious Diseases 2002; 186: 14831486.
12. Hahné, S, et al. Measles outbreak, the Netherlands, 2008. Emerging Infectious Diseases 2010; 16: 567568.
13. Van den Hof, S, et al. Sero-epidemiologic study of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in municipalities with low vaccine coverage. Vaccine 2000; 18: 931940.
14. De Melker, HE, Conyn-van Spaendonck, MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiology and Infection 1998; 121: 637643.
15. Van der Klis, FRM, et al. Second national serum bank for population-based seroprevalence studies in the Netherlands. Netherlands Journal of Medicine 2009; 67: 301308.
16. Smits, GP, et al. Development of a bead-based multiplex immunoassay for the simultaneously quantitative detection of IgG serum antibodies against measles, mumps, rubella and varicella zoster. Clinical Vaccine Immunology 2012; 19: 396400.
17. Chen, RT, et al. Measles antibody: reevaluation of protective titers. Journal Infectious Diseases 1990; 162: 10361042.
18. The R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2011.
19. Statistics Netherlands. Population on 1 January 2007 (http://www.cbs.nl). Accessed 1 January 2009.
20. Statistics Netherlands. Degree of urbaniziation per municipality (http://www.cbs.nl). Accessed 1 October 2007.
21. Ruijs, WLM, et al. Measuring vaccination coverage in a hard to reach minority. European Journal of Public Health 2012; 22: 359364.
22. Bickel, PJ, Doksum, KA. Basic heuristics of estimation. In: Bickel, PJ and Doksum, KA, eds. Mathematical Statistics. Basic Ideas and Selected Topics. London: Prentice-Hall, 2001, pp. 101.
23. Gay, NJ. The theory of measles elimination: implications for the design of elimination strategies. Journal Infectious Diseases 2004; 189 (Suppl. 1): 2735.
24. Wallinga, J, Heijne, JCM, Kretzschmar, M. A measles epidemic threshold in a highly vaccinated population. PLoS Medicine 2005; 2: e316.
25. Bartlett, MS. The critical community size for measles in the United States. Journal of the Royal Statistical Society. Series A (General) 1960; 123: 3744.
26. Ruijs, WL, et al. How orthodox protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health 2012; 12: 408.
27. Ruijs, WL, et al. How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study. BMC Health Services Research 2012; 12: 231.
28. Van 't Klooster, TM, de Melker, HE. The national immunisation programme in the Netherlands: developments 2012. Bilthoven, The Netherlands: National Institute for Public Health and the Environment, 2012. Report 201001002/2012.
29. Van den Hof, S, et al. Options for improvement of the Dutch measles vaccination schedule. Vaccine 2003; 21: 721724.
30. Lee, MS, et al. Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995–1997. Vaccine 2007; 19: 46444651.
31. Wetsteyn, JCFM, et al. Measles outbreak at the intensive care [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 2008; 152: 20322036.
32. Van den Hoek, A, et al. Two cases of mild IgM-negative measles in previously vaccinated adults, the Netherlands, April and July 2011. Eurosurveillance 2011; 16: pii = 20028.
33. Poethko-Müller, C, Mankertz, A. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titers in a German population-based cross-sectional study in children and adolescents (KiGGS). Vaccine 2011; 29: 79497959.
34. Christenson, B, Böttiger, M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994; 12: 129133.
35. Amela, C, Pachón, I, de Ory, F. Evaluation of measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. European Journal of Epidemiology 2003; 18: 7179.
36. Mossong, J, Putz, L, Schneider, F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiology and Infection 2003; 132: 1118.
37. Davidkin, I, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Journal of Infectious Diseases 2008; 197: 950956.
38. Rota, MC, et al. Measles serological survey in the Italian population: interpretation of results using a mixture model. Vaccine 2008; 26: 44034409.
39. Theeten, H, et al. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiology and Infection 2011; 139: 494504.
40. Parker, RA, Erdman, DD, Anderson, LJ. Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology. Journal of Virological Methods 1990; 27: 135144.
41. Vyse, AJ, et al. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiology and Infection 2006; 134: 13031312.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed